Showing results (171-180 of 1,748) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activityBrian I Rini, Ajit Paintal, Nicholas J Vogelzang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Major histocompatibility complex-restricted lysis of neuroblastoma cells by autologous cytotoxic T lymphocytesA K Sarkar, S M Burlingame, Y Q Zang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantationP Musk, S Szmania, A T Galloway, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Melanoma-Reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor typesM Harada, Y F Li, M El-Gamil, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
A humanized anti--4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primatesH J Hong, J W Lee, S S Park, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Coupling CD28 co-stimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and deathE J Beecham, Q Ma, R Ripley, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Anti-Tumor CC49-zeta CD4 T cells possess both cytolytic and helper functionsS D Patel, Y Ge, M Moskalenko, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factorT Lesimple, A Moisan, F Guillé, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 studyJeannette C Oosterwijk-Wakka, Dorien M Tiemessen, Ivar Bleumer, et al.Pageof 175